You are currently on our Canadian website.
Visit our international website at pharmalabiotech.com
What we do
PharmAla works with established, best- in-class laboratories across Canada to develop novel processes for the supply of LaNeo™ and other MDXX substances.
We hold ourselves to the highest standards of
compliance and rigour. Our Research and Development team is
engaged in preclinical research on 2 of our novel
chemical entities, with the goal of increasing the
safety of MDXX and its analogs.
Our Team
Our team consists of passionate professionals who are on the cutting edge of psychedelic research. We work closely with researchers across Canada and the US to develop and advance the research into novel patented compounds based around MDMA, as well as establishing MDMA delivery processes.
Nicholas Kadysh
Founding CEO, President
Will Avery
Chief Financial Officer
Harpreet Kaur
Vice President of Research
Jodi Butts
Board Chair
Kevin Roy
Chair of the Audit Committee
Fraser Macdonald
Director
Join our email list to have the latest news and developments sent directly to your inbox. You can unsubscribe any time.
